[Consumption coagulopathy in obstructive septic pyelonephritis].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D002228:Carbenicillin / Q000627:therapeutic use; D002512:Cephalothin / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy / Q000209:etiology*; D004877:Ergoloid Mesylates / Q000627:therapeutic use; D005165:Factor V; D005170:Factor X; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009921:Metaproterenol / Q000627:therapeutic use; D009638:Norepinephrine / Q000627:therapeutic use; D011516:Prothrombin; D011704:Pyelonephritis / Q000150:complications*; D018805:Sepsis; D012772:Shock, Septic / Q000150:complications / Q000188:drug therapy / Q000209:etiology* / Q000628:therapy
D000305:Adrenal Cortex Hormones; D009921:Metaproterenol; D004877:Ergoloid Mesylates; D005165:Factor V; D011516:Prothrombin; D005170:Factor X; D006493:Heparin; D002228:Carbenicillin; D002512:Cephalothin; D009638:Norepinephrine
Verbraunchskoagulopathie bei obstruktiver septischer Pyelonephritis.